1Das KM,Farag SA.Current medical therapy of inflammatory bowel disease.World J Gastroenterol 2000;6:483-489[PMID:11819634]. 被引量：1
2Pan BR,Hodgson HJF,Kalsi J.Hyperglobulinemia in chronic liver disease:Relationships between in vitro immunoglobulin synthesis,short lived suppressor cell activity and serum immunoglobulin levels.Clin Exp Immunol 1984;55:546-551.[PMID:6231144]. 被引量：1
3Lin GZ,Wagn XZ,Wang P,Lin J,Yang FD.Immunologic effect of Jianpi Yishen decoction in treatment of Pixu-diarrhoea.Shijie Huaren Xiaohua Zazhi 1999;7:285-287.[CMFAID:1082371101835979].Books and other monographs. 被引量：1
4Sherlock S,Dooley J.Diseases of the liver and billiary system.9th ed.Oxford:Blackwell Sci Pub,1993:258-296.Chapter in a book. 被引量：1
5Lam SK.Academic investigator's perspective of medical treatment for peptic ulcer In:Swabb EA,Azabo S,eds.Ulcer disease:investigation and basis for therapy.New York:Marcel Dekker,1991:431-450. 被引量：1
6Morse SS.Factors in the emergence of infectious diseases.Emerg Infect Dis serial online,1995-01-3,cited 1996-06-05;1(1):24 screens.Available from:URL:http//www.cdc.gov/ncidod/EID/eid.htm. 被引量：1
